Premium
Comparison of Three Cardioverter Defibrillator Implantation Techniques: Initial Results with Transvenous Pectoral Implantation
Author(s) -
ANVARI ANAHIT,
STIX GÜNTER,
GRABENWÖGER MARTIN,
SCHNEIDER BARBARA,
TUREL ZEYNEP,
SCHMIDINGER HERWIG
Publication year - 1996
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.1996.tb03414.x
Subject(s) - medicine , perioperative , surgery , concomitant , cardiac surgery , pectoral muscle , fibrous joint
A total of 121 patients underwent epicardial (n = 32), transvenous abdominal (n = 30), and transvenous pectoral (n = 59) ICD implants. Perioperative complications were defined as those occurring within 30 days after surgery. Hospital costs were calculated with $750 per day as a fixed charge. Duration of surgery was the time between the first skin incision and the last skin suture. Severe perioperative complications that were life‐threatening or required surgical intervention occurred in the epicardial (6%) and transvenous (10%) abdominal groups, but not in the pectoral group. Perioperative mortality occurred only in the epicardial abdominal group, predominantly in patients with concomitant surgery (18%), and in 5% of patients without concomitant surgery. The duration of surgery was significantly shorter for transvenous pectoral implantation (58 ± 15 rain, P < 0.05) compared to transvenous abdominal implantation (115 ± 38 min). Epicardial abdominal ICD implantation had the longest procedure time (154 ± 31 min). The postimplant hospital length of stay was significantly shorter for pectoral implantation (5 ± 3 days, P < 0.05) compared to transvenous (13 ± 5) and epicardial (19 ± 5) abdominal implantation. Total hospitalization costs significantly decreased in the pectoral implantation group ($4,068 ±$2,099 for the pectoral group vs $14,887 ±$4,415 and $9,975 ±$3,657 for the epicardial and the transvenous abdominal group, respectively, P < 0.05). These initial results demonstrate the advantage of transvenous pectoral ICD implantation in terms of perioperative complications, procedure time, hospital length of stay, and hospitalization costs.